Wire

Israel’s ALYN Hospital and Philadelphia International Medicine Join Forces to Advance Pediatric Medicine Worldwide

Israel’s ALYN Hospital, Pediatric & Adolescent Rehabilitation Center and Philadelphia International Medicine (PIM) announced a partnership today that aims to create a global healthcare space for pediatric care. Through the ALYN- PIM Health Gateway Initiative, the two medical institutions will collaborate on delivering medical education, joint research, and patient care among other efforts that will benefit the medical community internationally.

A collaboration announced today between two centers of excellence in the medical field could lead to international advances in pediatric care. ALYN Hospital, Pediatric & Adolescent Rehabilitation Center, Israel’s renowned pediatric rehabilitation center, and Philadelphia International Medicine (PIM), a provider of specialized services and education that connects ten leading Philadelphia-area medical centers with the international community, are partnering to establish the ALYN-PIM Health Gateway Initiative.

The ALYN-PIM Health Gateway Initiative marks PIM’s first official collaboration with an Israeli hospital. Within PIM’s network, the partnership will initially focus on Nemours Children’s Hospital, one of the largest and most respected pediatric medical institutions in the United States.

Through knowledge-sharing between physicians, research projects, professional meetings and more, the ALYN-PIM Health Gateway Initiative will advance education, assist in the sharing and developing of new techniques and technologies for treating pediatric patients, and, above all, improve patient care worldwide.

“Medical education, research, and innovation are ongoing activities at ALYN, and enhancing knowledge is always to our patients’ benefit,” said Dr. Maurit Beeri, Director General of ALYN Hospital. “Nemours has some of the best pediatric physicians in the United States. By partnering with PIM, we can build a valuable health gateway together, connecting our medical teams and professionals to bring immeasurable benefits and advance pediatric care worldwide.”

ALYN is recognized worldwide for its innovative approach to pediatric rehabilitation. A dedicated innovation space at the hospital, ALYNovation, specializes in developing cutting-edge technology that can improve the lives of children with disabilities, working with startups to accelerate the speed at which these technologies are able to help patients across the world.

“ALYN’s integrated and holistic approach to patient care and commitment to innovation make this partnership a natural fit,” said Edgar Vesga, CEO and President of PIM. “It is important to us that we can continue to make quality medical care available to international patients, and we see cooperation with ALYN as an ideal way to achieve this goal. Connecting Israel with Philadelphia opens many doors for both organizations to collaborate to improve the future of medicine.”

About & contact The Publishers
ALYN Hospital opened in 1932 to support children with orthopedic disabilities in Jerusalem. ALYN has grown into a unique medical facility and global leader in pediatric rehabilitation for children with physical disabilities, regardless of religious or ethnic background. ALYN offers a multidisciplinary and holistic approach to rehabilitation and is on the cutting-edge of assistive technology development to benefit children. Medical facilities, research institutions and technology companies throughout the world seek partnerships with ALYN to create meaningful advances in the field.
Releases published on the JNS Wire are communicated and paid for by third parties. Jewish News Syndicate, and any of its distribution partners, take zero responsibility for the accuracy of any content published in any press release. All the statements, opinions, figures in text or multimedia including photos or videos included in each release are presented solely by the sponsoring organization, and in no way reflect the views or recommendation of Jewish News Syndicate or any of its partners. If you believe any of the content in a release published on JNS Wire is offensive or abusive, please report a release.
Comments